These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2655218

  • 1. The impact of body weight on cyclosporine pharmacokinetics in renal transplant recipients.
    Flechner SM, Kolbeinsson ME, Tam J, Lum B.
    Transplantation; 1989 May; 47(5):806-10. PubMed ID: 2655218
    [Abstract] [Full Text] [Related]

  • 2. Obesity and renal transplantation.
    Merion RM, Twork AM, Rosenberg L, Ham JM, Burtch GD, Turcotte JG, Rocher LL, Campbell DA.
    Surg Gynecol Obstet; 1991 May; 172(5):367-76. PubMed ID: 2028371
    [Abstract] [Full Text] [Related]

  • 3. Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocrit.
    Yee GC, McGuire TR, Gmur DJ, Lennon TP, Deeg HJ.
    Transplantation; 1988 Sep; 46(3):399-402. PubMed ID: 3047931
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and clinical tolerance of intravenous and oral cyclosporine in the immediate postoperative period.
    Morse GD, Holdsworth MT, Venuto RC, Gerbasi J, Walshe JJ.
    Clin Pharmacol Ther; 1988 Dec; 44(6):654-64. PubMed ID: 3058372
    [Abstract] [Full Text] [Related]

  • 5. Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation.
    Okada Y, Nakasone H, Konuma T, Uchida N, Tanaka M, Sugio Y, Aotsuka N, Nishijima A, Katsuoka Y, Ara T, Ota S, Onizuka M, Sawa M, Kimura T, Fukuda T, Atsuta Y, Kanda J, Kimura F.
    Transplant Cell Ther; 2022 Aug; 28(8):504.e1-504.e7. PubMed ID: 35577325
    [Abstract] [Full Text] [Related]

  • 6. Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism.
    Awni WM, Kasiske BL, Heim-Duthoy K, Rao KV.
    Clin Pharmacol Ther; 1989 Jan; 45(1):41-8. PubMed ID: 2642778
    [Abstract] [Full Text] [Related]

  • 7. Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children.
    Lim SY, Woo S, Miller JL, Skrepnek GH, Henry ED, Johnson PN.
    Pediatr Crit Care Med; 2019 Dec; 20(12):e556-e564. PubMed ID: 31568259
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporine (cyclosporin A) pharmacokinetics in renal transplant patients receiving ciprofloxacin.
    Lang J, Finaz de Villaine J, Garraffo R, Touraine JL.
    Am J Med; 1989 Nov 30; 87(5A):82S-85S. PubMed ID: 2589391
    [Abstract] [Full Text] [Related]

  • 13. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y.
    Clin Pharmacokinet; 2004 Nov 30; 43(11):741-62. PubMed ID: 15301578
    [Abstract] [Full Text] [Related]

  • 14. The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients.
    Willcox A, Wong E, Nath C, Janson B, Harrison SJ, Hoyt R, Bajel A, Shaw P, Ritchie D, Grigg A.
    Ann Hematol; 2018 Dec 30; 97(12):2509-2518. PubMed ID: 30051172
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Should obese patients lose weight before receiving a kidney transplant?
    Modlin CS, Flechner SM, Goormastic M, Goldfarb DA, Papajcik D, Mastroianni B, Novick AC.
    Transplantation; 1997 Aug 27; 64(4):599-604. PubMed ID: 9293872
    [Abstract] [Full Text] [Related]

  • 17. Procainamide disposition in obesity.
    Christoff PB, Conti DR, Naylor C, Jusko WJ.
    Drug Intell Clin Pharm; 1983 Aug 27; 17(7-8):516-22. PubMed ID: 6191939
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.